Column 1 Column 2 Column 3 Column 4 Column 5 Column 6 0 10:14am AEST 0.025 1,000,000 25,000.00 People are still buying, sky hasn't fallen.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%